ATS 2019 Virtual Final Program

P65 Xpert MTB/RIF Ultra Sputum and Urine Testing and Determine LAM for Detection of Tuberculosis in Kampala, Uganda/ A.O. Andama, R.R. Crowder, D. Jaganath, L. Asege, M. Nakaye, D. Katumba, S. Mwebe, F. Semitala, M. Joloba, W. Worodria, S. Mohanty, A. Somoskovi, A. Cattamanchi, Kampala, Uganda, p.A5168 P66 Operational Feasibility and Diagnostic Yield of Urine TB-LAM Testing Among HIV-Infected Patients Hospitalized with Sepsis and Septic Shock in Uganda/ M.J. Cummings, B. Bakamutumaho, N. Owor, J. Kayiwa, T. Byaruhanga, B. Namagambo, A. Wolf, J.J. Lutwama, M.R. O’Donnell, New York, NY, p.A5169 Facilitator : P. Escalante, MD, Rochester, MN P67 Study on the Diagnostic Value of Interleukin-27 in the Tuberculous Pleurisy/ D. Wu, X. Chen, Y. Lin, L. Chen, Fuzhou, China, p.A5170 P68 Role of Loop Mediated Isothermal Amplification Assay in Detecting Mycobacterium Tuberculosis/ K. Jana, K.V.V.V. Kaminedi, Visakhapatnam, India, p.A5171 P69 Clinical Evaluation of the Molecular Bacterial Load Assay for Real-Time Monitoring of Tuberculosis Treatment Response/ B. Mtafya, W. Sabiiti, I. Sabi, Y. Msuya, N.E. Ntinginya, S.H. Gillespie, Mbeya, Tanzania, United Republic of, p.A5172 P70 Diagnostic Utility of Endobronchial Ultrasound Guided Trans-Bronchial Needle Aspiration for Suspected Tubercular Mediastinal Lymphadenopathy at a Tertiary Care Center in North India/ A. Mian, A.D. Singh, A. Ray, S. Mathur, S. Sinha, New Delhi, India, p.A5173 P71 Usefulness of the Tuberculosis-Specific Antigen/PHA Ratio in the T-SPOT.TB to Differentiate Between Active Tuberculosis Infection and Latent Tuberculosis Infection in Japan/ S. Katakura, N. Kobayashi, A. Kanai, H. Yagyu, R. Inoue, K. Murohashi, M. Ikeda, N. Masumoto, K. Nakashima, K. Yumoto, K. Tashiro, S. Teranishi, K. Nagai, K. Watanabe, A. Wakabayashi, Y. Hara, T. Sato, T. Kaneko, Yokohama, Japan, p.A5174 P72 The Positive Status of Latent Tuberculosis Infection Is More Consistent by QuantiFERON-TB Gold Plus than That by QuantiFERON-TB Gold In-Tube/ C.-C. Shu, Taipei, Taiwan, p.A5175 P73 Sensitivity and Specificity of an Electronic Nose in Diagnosing Pulmonary Tuberculosis Among Patients with Suspected Tuberculosis in Indonesia/ A. Saktiawati, Y. Stienstra, Y.W. Subronto, S. Sumardi, J.-W. Gerritsen, H. Oord, O.W. Akkerman, T.S. van der Werf, Yogyakarta, Indonesia, p.A5176 Facilitator : T. Scriba, PhD, Cape Town, South Africa P74 Respiratory Specimens for the Diagnosis of Pediatric Pulmonary Tuberculosis: A Comparative Assessment/ M. Singh, G.R. Sethi, M. Mantan, A. Khanna, M. Hanif, Chandigarh, India, p.A5177 P75 Diagnostic Yield of Sputum Induction in Pleural Tuberculosis Patients at a Tertiary Care Hospital in Karachi/ N.A. Rizvi, K.K. Sumalani, N. Akhter, D. Chawla, Karachi, Pakistan, p.A5178 P76 Clinical Significance of Isolation of Mycobacterium Tuberculosis Among Patients with Non-Tuberculous Mycobacteria/ C. Nishio, H. Konishi, T. Ochi, K. Oh, H. Tomioka, Kobe, Japan, p.A5179 P77 Effect of Prior Intake of Amoxicilline-Clavulanic Acid in the Detection of Acid-Fast Bacilli on Direct Examination of Bronchial Secretions/ E. Justin, K. Thiam, N. Toure, Y. Dia, F. Bintou, M. Cisse, S. Musangu, C. Kibulungu, A. Jeillany, Dakar, Senegal, p.A5180 P78 Automated Ordering of Nucleic Acid Amplification Testing Leads to Significant Reduction in Airborne Infectious Isolation for Pulmonary Tuberculosis/ B. Garnet, K. Tovar, R. McDade, O. Martinez, L. Abbo, D. Ashkin, M.A. Campos, Miami, FL, p.A5181 P79 Diagnostic Accuracy of C-Reactive Protein for Active TB in Adults Without HIV: A Cross-Sectional Study/ J.L. Davis, A. Meyer, E. Ochom, P. Byanyima, A. Cattamanchi, W.O. Worodria, L. Huang, New Haven, CT, p.A5182 BEHAVIORAL THEMATIC POSTER SESSION C56 HIV: CLINICAL STUDIES AND BASIC SCIENCE MODELS 9:15 a.m. - 4:15 p.m. KBHCCD Area A (Hall F, Level 2) Viewing: Posters will be on display for entire session. Discussion: 11:15-12:00: authors will be present for individual discussion 12:00-1:00: authors will be present for discussion with assigned facilitators. Facilitator : K.A. Crothers, MD, Seattle, WA P81 Doxycycline Treatment Reduced BAL MMP-9 Levels in HIV-Positive Individuals with COPD or Early Emphysema: A Pilot Study/ R.J. Kaner, S.L. O’Beirne, K.M.F. Khan, T.J. Walsh, R.G. Crystal, M.J. Glesby, New York, NY, p.A5183 P82 Characteristics Associated with COPD in People Living with HIV in the Current Antiretroviral Therapy (ART) Era/ J.S. Zifodya, B.M. Whitney, R.M. Nance, J.A.C. Delaney, B.N. Harding, S.R. Heckbert, W.C. Mathews, A.L. Durr, R.D. Moore, M.J. Mugavero, M.S. Saag, M.M. Kitahata, H.M. Crane, K.A. Crothers, Seattle, WA, p.A5184 P83 Marijuana Use and Its Association with Markers of Lung Disease in People Living with HIV/ D. Wenger, M. Triplette, S. Shahrir, K.M. Akgun, C. Wongtrakool, S.T. Brown, J.W. Kim, G.W. Soo Hoo, M. Rodriguez-Barradas, L. Huang, L.C. Feemster, K.A. Crothers, Seattle, WA, p.A5185 P84 Investigation of Microbial Communities in the Gut-Lung Axis of Human Immunodeficiency Virus-Infected Donors/ J.S.W. Yang, D.A. Ngan, J. Leung, D.D. Sin, S.-F.P. Man, Vancouver, Canada, p.A5186 P85 The Association of Lung Function with Acute Care Events and HIV Related Quality of Life in a High-Risk AIDS Cohort/ S. Raju, M.B. Drummond, R.H. Brown, C.A. Merlo, G.D. Kirk, M.C. McCormack, Baltimore, MD, p.A5187 P86 MicroRNA-144 Mediates Alveolar Macrophage Dysfunction in HIV-1 Transgenic Rats/ S. Murray, X. Fan, B.S. Staitieh, D.M. Guidot, Atlanta, GA, p.A5188 ATS 2019 • Dallas, TX TUESDAY • MAY 21 269 TUESDAY MORNING